3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Liver Neoplasms
1
Hepatitis B
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Hepatocellular
1
Interventions
Drug Therapy
3
Radiotherapy
2
uridine triacetate
1
camrelizumab
1
bismuth tripotassium dicitrate
1
Telbivudine
1
Tegafur
1
Surgical Procedures, Operative
1
Pharmaceutical Services
1
Ofloxacin
1
Octreotide
1
Metronidazole
1
Levofloxacin
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gemcitabine
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Esomeprazole
1
Docetaxel
1
Dihydrouracil Dehydrogenase (NADP)
1
Clarithromycin
1
Cisplatin
1
Celecoxib
1
Capecitabine
1
Amoxicillin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
Telbivudine
×
Gastrointestinal
×
Clear all
NCT01102335
2010-04-13
TACEHBV
Fudan University
Phase 4
Unknown
80 enrolled